Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122180) titled 'Research on the Mechanism of Escaping the CRISPR-Cas Defense System of Pseudomonas aeruginosa by Carrying the blaKPC-2 Plasmid' on April 9.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Shenzhen People's Hospital
Condition:
Carbapenem-resistant Pseudomonas aeruginosa infection
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-15
Target Sample Size: CRISPR-Cas positive and CRISPR-Cas negative CRPA:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=299867
Published by HT Digital Content ...